article thumbnail

Generics propelling pharmaceutical parenteral packaging market

European Pharmaceutical Review

Research on the global pharmaceutical parenteral packaging market by InsightAce Analytic Pvt. Main drivers for the market were reported to be rising popularity of generics together with blockbuster and other small-molecule drugs going off-patent globally. has predicted that the sector will value $18.85 billion by 2031. Catalent Inc.

article thumbnail

STAT+: ‘Like playing the lottery’: A mixed picture for laid-off life sciences workers in Massachusetts

STAT

The big blow to Sunovion, he said, was the loss of patent protection for Latuda, its best-selling schizophrenia drug, which led to competition from cheaper generic medicines. “The severance package that I received from Sunovion was very generous and will tide me over until December,” he said. Absolutely.”

Vaccines 337
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Parallel import of medicinal products: regulatory update

European Pharmaceutical Review

This is due to the regulatory requirements imposed on parallel imported medicinal products in various Member States, the fulfilment of which often requires repackaging. Repackaging a medicinal product… means that the trademark is reapplied by an entity other than the trademark proprietor.”

article thumbnail

Mankind Pharma launches 120 DMF quality drugs for Indian patients

Express Pharma

The Drug Master File (DMF) has all the information on an API (Active Pharmaceutical Ingredient/Raw material for medicine) Mankind Pharma has introduced 120 DMF (Drug Master File) Quality Medicines in the Indian market. This initiative aims to ensure universal access to medicines of international calibre.

article thumbnail

Accelerating pharma’s sustainability efforts

Express Pharma

Integrating ESG considerations into core pharma operations India, known as the “Pharmacy of the World,” produces over 20 per cent of the global supply of generic medicines and plays a vital role in vaccine production, as per the Investindia.gov.in It meets the healthcare needs of over 1.4

article thumbnail

Halting Europe’s essential medicines manufacturing exodus

European Pharmaceutical Review

The recent update to the EC Urban Waste Directive, part of the environment package ‘Towards Zero Pollution,’ 4 has a disproportionate producer responsibility principle that will incur considerable extra costs. This is likely to make some essential medicines and APIs economically unsustainable to manufacture.

article thumbnail

USP’s commitment to ESG considerations for a healthier, more sustainable world

Quality Matters

For separate external shipping containers, USP has also reduced the need for plastic wrap and is evaluating smaller container sizes and biodegradable packaging materials, as well as a more easily recyclable alternative to EPS for cold-chain applications. In addition, they are more compact and 44% lighter than previous versions, on average.